Citius Pharmaceuticals Inc (NASDAQ:CTXR) is retreating on Monday after gaining about 20% last week.
As of 11:21, CTXR stock fell 3.82% to $2.26. The stock has traded 1.70 shares, compared to its average volume of 8.10 million shares. After opening at $2.35, the stock has moved within a wide range of $2.2300 – 2.3600.
CTXR Had News Last Week
Citius Pharmaceuticals, Inc. Announces Appointment of Ilanit Allen as Vice President, Corporate Communications and Investor Relations
- CTXR announced that Ilanit Allen has been appointed Vice President of Corporate Communications and Investor Relations, effective immediately. In this newly created role, Ms. Allen will spearhead financial communication and investor activities, reporting to Myron Holubiak, President and Chief Executive Officer of Citius.
“We are thrilled to welcome Ilanit to the Citius team as we advance our pipeline of first-in-class critical care products,” stated Mr. Holubiak. “I am confident that Ilanit’s extensive communications and investor relations experience, coupled with her financial and strategic mindset, will be an invaluable resource for our investors and the broader financial community. With multiple expected milestones on the horizon, we look forward to leveraging Ilanit’s expertise in communicating the Citius story with our stakeholders.”
|SHARES OUTSTANDING||135.47 M|
|SHARE FLOAT (%)||123.10 M (90.86%)|
|% HELD BY INSTITUTIONS||12.62|
Recent Stock Performance
|+/- EMA(20)||2.12 (+6.13%)|
|+/- SMA(50)||1.97 (+14.21%)|
|+/- SMA(200)||1.38 (+63.04%)|
|CCI20||101.6363||Buy||Chaikin Money Flow||0.0981||Buy|
|MACD||0.0902||Buy||Money Flow Index||50.1267||Sell|
|STOCH (14,3)||89.4737||OverBought||STOCH RSI||1.0000||OverBought|